Jacobio Pharma Announces 2024 Annual Results

BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act

Home 1 2 3 4 Next Tail

10 Items Per Page (Page 1 / 97) Total 963 Items

©copyright 2009-2020 Bot Ai Daily      Contact Us   SiteMap